BONE BIOLOGICS CORP (BBLG)

Bone Biologics Announces Closing of $2.0 Million Public Offering

Bone Biologics Announces Pricing of $2.0 Million Public Offering

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday morning!

Bone Biologics Reports Progress With NB1 Clinical Program

Bone Biologics files to sell common stock and warrant (NASDAQ:BBLG)

Bone Biologics files prospectus for sale of common stock and warrant, clarifying it is not an offer to sell.

Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors

Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

Bone Biologics files to sell 142.4K shares for its holders (NASDAQ:BBLG)

Bone Biologics (BBLG) has filed a prospectus for the proposed resale of 142K common shares; however, it is not an offer to sell these securities.

BBLG Stock Earnings: Bone Biologics Misses EPS for Q1 2023

BBLG stock results show that Bone Biologics missed analyst estimates for earnings per share the first quarter of 2023.

BBLG Stock Earnings: Bone Biologics Misses EPS for Q1 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bone Biologics (NASDAQ:BBLG) just reported results for the first quarter of 202...

BBLG Stock Earnings: Bone Biologics Misses EPS for Q2 2023

BBLG stock results show that Bone Biologics missed analyst estimates for earnings per share the second quarter of 2023.

BBLG Stock Earnings: Bone Biologics Misses EPS for Q2 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bone Biologics (NASDAQ:BBLG) just reported results for the second quarter of 20...

BBLG Stock Earnings: Bone Biologics Misses EPS for Q3 2023

BBLG stock results show that Bone Biologics missed analyst estimates for earnings per share the third quarter of 2023.

BBLG Stock Earnings: Bone Biologics Misses EPS for Q3 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bone Biologics (NASDAQ:BBLG) just reported results for the third quarter of 202...

Bone Biologics to conduct 1-for-8 reverse stock split (NASDAQ:BBLG)

Bone Biologics (BBLG) plan to conduct a 1-for-8 reverse stock split on Dec. 20, with split-adjusted shares trading that day. Read more here.

Bone Biologics Announces 1-for-8 Reverse Stock Split

Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules